Technology | December 12, 2014

Solution tracks, analyzes and mitigates radiation risk for both clinicians and patients; facilitates compliance with increased dose monitoring standards

Radiation dose management, RSNA 2014, CT systems, Information technology

Images courtesy of Philips

Radiation dose management, RSNA 2014, CT systems, Information technology
Radiation dose management, RSNA 2014, CT systems, Information technology

December 12, 2014 — Philips Healthcare introduced the DoseWise Portal, a comprehensive radiation dose management software solution aimed at managing radiation exposure risk to patients and their caregivers at RSNA 2014. Philips DoseWise Portal enables health care providers to proactively record, analyze and monitor imaging radiation dose for patients and clinicians across multiple diagnostic settings.

While the risk of radiation exposure through imaging scans is thought to be low, and the diagnostic rewards generally outweigh those risks, the industry has committed to reducing radiation exposure through improvements in technology and user training. CT scans are of most concern, with a higher average diagnostic radiation dose per scan and nearly 68 million performed annually in the United States

"Dose management is a critical issue, and the reality is that sometimes the higher radiation dose of a CT is necessary for a particular patient to in order reach a definitive diagnosis, in the shortest time, and at the lowest cost," said Gene Saragnese, executive vice president and CEO of Philips Imaging Systems.

Over the past several years, industry standards like MITA XR-29 have provided health care providers with more standardized tools for patient radiation dose management. At the same time, hospitals and health systems looking to better protect patients and clinicians have been forced to tackle the problem independently, using multiple vendors to bring dose management into focus. Philips DoseWise Solutions include a comprehensive portfolio of products and services including ClarityIQ, IMR and DoseAware, that empower health care providers with both the data and support they need to implement a broad and comprehensive dose management strategy.

"Understanding and delivering the right dose for each person each time, and tracking and analyzing exposure over time, requires more than just technology, but also involves a new way managing radiation safety," said Christoph Wald, M.D., Ph.D. and executive vice chair, department of radiology at Lahey Hospital and Medical Center in Burlington, Maryland.

For more information: www.philips.com/healthcare

 


Related Content

News | X-Ray

April 29, 2026 — Results from a new study* presented at the American Roentgen Ray Society’s (ARRS) 2026 annual meeting ...

Time April 29, 2026
arrow
News | Imaging Software Development

April 28, 2026 — Avatar Medical has been granted FDA 510(k) clearance for Avatar Medical Vision, its software platform ...

Time April 28, 2026
arrow
News | Cardiac Imaging

April 28, 2026 — Abbott has received U.S. Food and Drug Administration (FDA) clearance and CE Mark for its next ...

Time April 28, 2026
arrow
News | Artificial Intelligence

April 20, 2026 — DeepTek, provider of the Augmento platform and deepc, the company behind deepcOS, have introduced a ...

Time April 23, 2026
arrow
News | FDA

April 16, 2026 — Royal Philips has received U.S. Food and Drug Administration 510(k) clearance for the Philips Spectral ...

Time April 20, 2026
arrow
News | Radiology Imaging

April 7, 2026 — Onvida Health and Siemens Healthineers have entered a 10-year Value Partnership¹ designed to bring the ...

Time April 09, 2026
arrow
News | Radiology Business

March 31, 2026 — Radon Medical Imaging, a medical imaging equipment maintenance and repair services company, has has ...

Time March 31, 2026
arrow
News | Radiology Imaging

March 26, 2026 — GE HealthCare has announced a renewed research collaboration with Stanford Medicine Department of ...

Time March 30, 2026
arrow
News | Cardiac Imaging

March 28, 2026 — When Ashley Perlow felt a sharp pain shoot across her chest and into both wrists, she didn't think it ...

Time March 30, 2026
arrow
News | FDA

March 24, 2026 — MARS Bioimaging, a New Zealand–headquartered medical device company, has received U.S. Food and Drug ...

Time March 25, 2026
arrow
Subscribe Now